2012 Deep Research Report on China Influenza Vaccine Industry

This research on Chinese influenza vaccine market has 155 Tables and Figures and is a professional and in-depth report. Firstly the study describes the background knowledge of Influenza Vaccine, including Concepts, Classification, Manufacturing process, technical parameters and equipments List, etc.

Statistics of International and China's 16 Manufacturers of Influenza Vaccine product with data for 2009-2016 Capacity production, cost, price, production value, profit margins and other relevant data are covered. In addition to these statistics of enterprises manufacturing Influenza Vaccine products, Product Specifications, company background information, summary statistics and analysis of relevant data on these enterprises is included in this report. The report has Global and China Influenza Vaccine companies' production market share, demand supply and shortage in China for Influenza Vaccine, 2009-2016 production, price, cost, profit, production value, profit margins, production market share by different Sources(China Domestic and Imported etc) are covered for the China Influenza Vaccine market.

At the same time, the report analyzes and discusses supply and demand changes in Influenza Vaccine industry and business development strategies, conducting a comprehensive analysis on China Influenza Vaccine industry trends. Finally, the report introduces 8Million Pieces/year Influenza Vaccine project Feasibility analysis and related research conclusions.

In a word, it is an in-depth research report on China Influenza Vaccine industry. And thanks to the support and assistance from Influenza Vaccine industry chain related experts and enterprises during QYResearch Vaccine Research Team survey and interview.

Chapter One Influenza Vaccine Industry Overview 1
1.1 Definition 1
1.2 Classification 2
1.2.1 Seasonal Influenza Vaccine 2
1.2.2 Type A H1N1 Influenza Vaccine 4
1.2.3 Two Type Influenza Vaccine Comparison 6
1.3 Vaccine Inoculation 7
1.4 Industry Chain Structure 9
1.5Influenza Vaccine Development Prospect 15
1.5.1 United States Overplus 15
1.5.2 Seek Competitive Differentiation New Technology Prevalence 17
1.5.3 Huge Market Demand in China 18

Chapter Two Influenza Vaccine Manufacturing Technology and Process 19
2.1 Influenza Vaccine Manufacturing Technology Overview 19
2.1.1 Embryo Culture Type A H1N1 Influenza Vaccine Manufacturing Process 20
2.1.2 Vero Cell Culture Inactivated Influenza Vaccine Manufacturing Process 23
2.2 Comparison of Two Procee Method 26
2.2.1 Embryo Culture Inactivated Influenza Vaccine Process Flow 26
2.2.2 Cell Culture Inactivated Influenza Vaccine Process Flow 27
2.2.3 Two Manufacturing Process Comparison 28
2.3 Influenza Vaccine Manufacturing Equipments List 30
2.4 Influenza Vaccine Manufacturing Process Today and Tomorrow 33
2.4.1 Influenza Vaccine Manufacturing Process Status 33
2.4.2 H1N1 Influenza Vaccine Manufacturing Process Problems 33
2.4.3 Influenza Vaccine New Manufacturing Technology 34

Chapter Three Influenza Vaccine Production Supply Sales Demand Market Status and Forecast 38
3.1 Influenza Vaccine Productions Overview 38
3.2 Influenza Vaccine Demand Overview 49
3.4 Influenza Vaccine Cost Price Production Value Gross Margin 53

Chapter Four Influenza Vaccine Key Manufacturers 57
4.1 Hualan Bio (Henan) 57
4.2 Sinovac (Beijing) 65
4.3 Tianyuan Bio-pharma (Zhejiang) 73
4.4 Changsheng (Jilin Changchun) 77
4.5 Aleph Biomedical (Liaoning) 81
4.6 SIOBP (Shanghai) 87
4.7 CCBIO (Jilin Changchun) 91
4.8 Lanzhou Institute of Biological Products (Qinghai) 95
4.9 Tiantan Biological (Beijing) 99
4.10 Sanofi-pasteur (France) 105
4.11 GSK (UK) 109
4.12 Novartis (Switzerland) 116
4.13 Abbott (US) 122
4.14 Crucell (Holland) 125
4.15 Tasly&Jenner (Tianjin) 130
4.16 Neptunus Interlong (Shenzhen) 134

Chapter Five China 8Million Pieces/Year Influenza Vaccine Project Investment Feasibility Analysis 139
5.1 China 8Million Pieces/Year Influenza Vaccine Project Opportunities and Risks Analysis 139
5.1.1 Opportunities 139
5.1.2 Risks 140
5.3 China 8Million Pieces/Year Influenza Vaccine Project Investment Feasibility Analysis 140
5.3.1 Project Overview 141
5.3.2 Capacity 141
5.3.3 Construction Standards 141
5.3.3 Construction Period 141
5.3.4 Project Schedule 141
5.3.5 Investment Feasibility Analysis 142

Chapter Six Influenza Vaccine Industry Research Conclusions 143

Tables and Figures

Table Common Vaccines Classification 2
Table Three Type Influenza Vaccine (Inactivated Whole Virus Vaccine Split Vaccine Subunit Vaccine) Characteristic Comparison 4
Table United States Approval Type A influenza H1N1 Vaccine Suppliers and Product Specifications List 5
Table Europe Approval Type A influenza H1N1 Vaccine Suppliers and Product Specifications List 6
Figure China First Type Vaccine and Second Type Vaccine Classification and Application 10
Table First Type Vaccine and Second Type Vaccine Detail Market Analysis 10
Table 2009-2010 China First Type Vaccine and Second Type Vaccine Issue Number (10K Pieces) and Market Share 11
Figure 2010 State-owned Private Foreign Enterprise Market Share in First Type Vaccine and Second Type Vaccine 11
Figure Influenza Vaccine Industry Chain Structure 12
Figure Vaccine Cold Chain Circulation System 13
Figure Vaccine Transportation Model 13
Figure First Type Vaccine Transportation Channel 14
Figure Second Type Vaccine Transportation Channel 14
Figure Vaccine Transportation Steps and Process 15
Figure 2009-2019 Global Influenza Vaccine Market Scale(100 Million USD) 16
Figure 2007-2008 United States TOP5 Suppliers Influenza Vaccine Market Share 17
Figure China Influenza Vaccine Inoculation Coverage Rate and Its Gap to International Goal 18
Table Baxter Vero Cell Platform Background Information 23
Figure Embryo Culture Inactivated Vaccine Manufacturing Process Flow 26
Figure Cell Culture Inactivated Influenza Vaccine Manufacturing Process Flow 27
Figure Two Influenza Vaccine Manufacturing Process Comparison 28
Figure Influenza Vaccine Manufacturing Steps 30
Figure Influenza Vaccine Detection Steps 31
Table Influenza Vaccine Manufacturing Equipments List (38 Equipments) 32
Figure Influenza Vaccine Production Periodic Table 33
Figure Influenza Vaccine Production schedules 34
Table Influenza Vaccine Development History 35
Table Existing and R&D Influenza Vaccine Products List 35
Figure Influenza Vaccine New Manufacturing Technology 37
Table China 11 Manufacturers Influenza Vaccine Market Status List 38
Table Selling Influenza Vaccine in China 5 Foreign Suppliers List 39
Table 2009-2016 China 11 Manufacturers Influenza Vaccine Capacity and Total Capacity (10K Pieces) List 40
Table 2009-2016 China 11 Manufacturers Influenza Vaccine Capacity Market Share List 40
Table 2009-2016 China 11 Manufacturers Influenza Vaccine Production and Total Production (10K Pieces) List 41
Table 2009-2016 China 11 Manufacturers Influenza Vaccine Production Market Share List 42
Table 2009-2016 China Influenza Vaccine Capacity Production (10K Pieces) and Capacity Utilization Rate 42
Figure 2009-2016 China Influenza Vaccine Capacity Production (10K Pieces) and Growth Rate 43
Figure 2011 China Key Manufacturers Influenza Vaccine Production Market Share (China Government Approcal Data) 43
Table 2009-2016 Global Key Suppliers Influenza Vaccine Capacity and Total Capacity (100 Million Pieces) List 43
Table 2009-2016 Global Key Suppliers Influenza Vaccine Production and Total Production (100 Million Pieces) List 44
Figure 2009-2016 Global Influenza Vaccine Capacity Production (100 Million Pieces) and Growth Rate 44
Table 2009-2016 Global Influenza Vaccine Capacity Production (100 Million Pieces) and Capacity Utilization Rate 45
Figure 2011 Global Key Suppliers Influenza Vaccine Production Market Share 45
Table 2009-2016 Global Key Suppliers Influenza Vaccine China Sales (10K Pieces) List 45
Figure 2011 China Imported Influenza Vaccine Market Share By Suppliers (China Government Approval Data) 46
Table Global and China Key Suppliers Key Vaccine Products Sales in China 46
Table 2007-2011 China Influenza Vaccine Approval Amount by Suppliers (10K Pieces) 47
Figure 2011 China Influenza Vaccine Market Share by Splitting Vaccine and Subunit Vaccine (according China government approval amount) 48
Table 2009-2016 China local Influenza Vaccine and Imported Influenza Vaccine Market Share Comparison 48
Table 2001-2020 China Birth Rate and Population (10K) 49
Figure China India Korea Japan etc 9 Countries Child Mortality (‰) 49
Figure 1950-2050 China Working-age Population Proportion (%) 50
Table 2000-2050 China Age Over 60 Population (100 Million) and Proportion (%) 50
Figure 2010-2050 China Age Over 60 Over 65 Over 80 Population Proportion 51
Table 2001-2015 China Per Capita GDP (USD) and Growth Rate 51
Figure 2009-2016 China Influenza Vaccine Supply Demand (10K Pieces) and Growth Rate 52
Figure China Japan France etc 9 Countries Age Over 65 Population Influenza Vaccine Inoculation Coverage Rate 52
Table 2009-2016 China Influenza Vaccine Supply Demand and Shortage (10K Pieces) 53
Table 2011 Hangzhou Disease Control and Prevention Center 33 Type Influenza Vaccine Products Purchase and Selling Price (RMB/Piece) 53
Table 2011 China and Imported Influenza Vaccine Capacity Production (10K Pieces) Price Cost Profit (RMB/Piece) Gross Margin List 56
Table 2009-2016 China Influenza Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 56
Table Hualan Bio Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 57
Figure Hualan Bio Vaccine Factory Picture 58
Figure Hualan Bio Influenza Virus Split Vaccine (Childhood Type) 59
Figure Hualan Bio Influenza Virus Split Vaccine (Adult Type) 61
Figure Hualan Bio Type A H1N1 Influenza Virus Split Vaccine 62
Table 2009-2016 Hualan Bio Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 64
Figure 2009-2016 Hualan Bio Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 64
Table Sinovac Biotech Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 65
Table Sinovac Biotech Vaccine Plant Picture 66
Table Sinovac Biotech Development History Time Table 66
Figure Sinovac Biotech Influenza Virus Split Vaccine-Anrlaifu 67
Figure Sinovac Biotech Pandemic Influenza Virus Inactivated Vaccine - Panrlaifu 69
Figure Sinovac Biotech Type A H1N1 Influenza Virus Split Vaccine - Panrlaifu.1 71
Table 2009-2016 Sinovac Biotech Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 72
Figure 2009-2016 Sinovac Biotech Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 73
Table Tianyuan Bio-pharma Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 73
Figure Tianyuan Bio-pharma Influenza Vaccine Products List 75
Figure Tianyuan Bio-pharma Influenza Virus Split Vaccine - Yuganning 75
Table 2009-2016 Tianyuan Bio-pharma Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 76
Figure 2009-2016 Tianyuan Bio-pharma Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 77
Table Changsheng Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 77
Figure Changsheng Influenza Virus Split Vaccine - Wanxin 79
Figure Changsheng Type A H1N1 Influenza Virus Split Vaccine 80
Table 2009-2016 Changsheng Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 80
Figure 2009-2016 Changsheng Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 81
Table Aleph Biomedical Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 81
Table Aleph Biomedical Contact Information List 82
Figure Aleph Biomedical Influenza Vaccine Manufacturing Workshop 83
Figure Aleph Biomedical Influenza Virus Split Vaccine(Adult Type) 84
Figure Aleph Biomedical Influenza Virus Split Vaccine (Childhood Type) 85
Table 2009-2016 Aleph Biomedical Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 86
Figure 2009-2016 Aleph Biomedical Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 86
Table SIOBP (Shanghai Institute of Biological Products) Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 87
Figure CNBG and Six Institutes Equity Relationship 88
Figure SIOBP Influenza Virus Split Vaccine 89
Figure SIOBP Type A H1N1 Influenza Virus Split Vaccine 89
Table 2009-2016 SIOBP Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 90
Figure 2009-2016 SIOBP Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 91
Table CCBIO(Changchun Institute of Biological Products) Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 91
Figure CCBIO Influenza Split Vaccine - Shipulir 93
Figure CCBIO Factory Workshop Picture 93
Table 2009-2016 CCBIO Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 94
Figure 2009-2016 CCBIO Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 95
Table Lanzhou Institute of Biological Products Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 95
Figure Lanzhou Institute of Biological Products Factory Picture 97
Figure Lanzhou Institute of Biological Products Trivalent Influenza Split Vaccine 97
Table 2009-2016 Lanzhou Institute of Biological Products Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 97
Figure 2009-2016 Lanzhou Institute of Biological Products Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 98
Table Tiantan Biological Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 99
Figure Tiantan Biological Control Shares of Sinopharm 101
Figure Tiantan Biological and Related Control Subsidiaries Relationship 101
Figure Tiantan Biological Factory Picture 102
Figure Tiantan Biological Beijing Yizhuang Vaccine Plants Picture 102
Figure Tiantan Biological Type A H1N1 Influenza Virus Split Vaccine 103
Figure Tiantan Biological Influenza Virus Split Vaccine 103
Table 2009-2016 Tiantan Biological Influenza Virus Split Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 104
Figure 2009-2016 Tiantan Biological Influenza Virus Split Vaccine Capacity Production (10K Pieces) and Growth Rate 105
Table Sanofi-pasteur Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 105
Figure Sanofi-pasteur China Pharmaceutical Factories Distribution 107
Figure Influenza Virus Split Vaccine-Fanrling 107
Table 2009-2016 Sanofi-pasteur Influenza Virus Split Vaccine Capacity Production (100Million Pieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 108
Figure 2009-2016 Sanofi-pasteur Influenza Virus Split Vaccine Capacity Production (100Million Pieces) and Growth Rate 109
Table GSK Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 110
Figure GSK Shenzhen Influenza Vaccine Workshop Pictures 113
Figure GSK Influenza Split Vaccine - Fululishi 114
Table 2009-2016 GSKInfluenza Virus Split Vaccine Capacity Production (100Million Pieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 114
Figure 2009-2016 GSKInfluenza Virus Split Vaccine Capacity Production (100Million Pieces) and Growth Rate 115
Table Novartis Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 116
Figure Novartis Subunit Influenza Vaccine - Agrippal 119
Figure Novartis Aged Population Special Use Influenza Vaccine - Fluad 120
Table 2009-2016 Novartis Influenza Virus Subunit Vaccine Capacity Production (100Million Pieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 121
Figure 2009-2016 Novartis Influenza Virus Subunit Vaccine Capacity Production (100Million Pieces) and Growth Rate 121
Table Abbott Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 122
Figure Abbott Influenza Subunit Vaccine - Influvac 124
Table 2009-2016 Abbott Subunit Influenza Vaccine Capacity Production (100Million Pieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 124
Figure 2009-2016 Abbott Subunit Influenza Vaccine Capacity Production (100Million Pieces) and Growth Rate 125
Table Crucell Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 126
Table Crucell Selling Vaccines and R&D Projects List 128
Table Crucell V Type Virion Adjuvant Influenza Vaccine (Subunit ) - Inflexal 129
Table 2009-2016 Crucell Subunit Influenza Vaccine Capacity Production (100Million Pieces) China Sales (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 129
Table 2009-2016 Crucell Subunit Influenza Vaccine Capacity Production (100Million Pieces) and Growth Rate 130
Table Tasly&Jenner Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 130
Figure Tasly&Jenner Factory Pictures 132
Figure Tasly&Jenner Subunit Influenza Virus Split Vaccine-Fuluoke® 132
Table 2009-2016 Tasly&Jenner Influenza Virus Subunit Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 133
Table 2009-2016 Tasly&Jenner Influenza Virus Subunit Vaccine Capacity Production (10K Pieces) and Growth Rate 134
Table Neptunus Interlong Company Information Table(Products Development History Location Background Contact Information etc 14 Items) 134
Figure Neptunus Interlong Vaccine Factory Picture 136
Figure Neptunus Interlong Vaccine Workshop Picture 136
Figure Neptunus Interlong Influenza Subunit Vaccine Package 137
Table 2009-2016 Neptunus Interlong Influenza Virus Subunit Vaccine Capacity Production (10K Pieces) Price Cost Gross (RMB/Piece) Production Value (10K RMB) Gross Margin List 138
Table 2009-2016 Neptunus Interlong Influenza Virus Subunit Vaccine Capacity Production (10K Pieces) and Growth Rate 138
Table China 8Million Pieces/Year Influenza Vaccine Project Investments List 140
Table China 8Million Pieces/Year Influenza Vaccine Project Investment Feasibility Analysis 142